High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
about
Current and emerging azole antifungal agentsClinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditionsFluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsThe use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsComparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.Immune restoration diseases reflect diverse immunopathological mechanisms.HIV in Africa: Challenges and Directions for the Next Decade.Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients.[Cryptococcal meningitis and bone tuberculosis in an immunocompetent: a case].Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.High-dose therapy with fluconazole > or = 800 mg day-1.Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.New agents for the treatment of systemic fungal infections--current status.Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.The war on cryptococcosis: A Review of the antifungal arsenal.Recommendations for the treatment of established fungal infections
P2860
Q24550733-C6077ED8-3FC4-45F8-A9F8-78C7DE0D1934Q28365296-C0DE0F6E-01E0-4429-A4B3-D9AFEDE9C182Q30435365-A3DE9223-B219-4EE7-A6E1-F6824CA176E9Q33788619-D97693E9-9113-4745-AC84-D3C4226CE177Q34020746-255390E5-6B00-461B-B04B-22DC073EB787Q34516548-D5BF1F64-7BA5-4175-8933-2F9DBD4A7AD0Q35628245-600DA358-4C84-4015-82C6-F26B384E19D4Q37409995-FC70C8DA-9391-41BE-9A58-0EDCBF41DF93Q38419599-B5CB5F37-7AB0-4540-8955-76ACE7DBCDB2Q39242940-902D44EA-B7C2-4200-BDAC-95DADCF91B78Q41151513-D2D11F0C-2185-4D99-BC8C-FC9A7CADF95AQ41708431-BBEAFE9A-7E40-4EE2-ADCC-970A02AE58D2Q41708449-292622A3-056B-4FB2-9B51-6DFCD4F63CA7Q46248271-7333832F-8466-4DAD-B3DA-43637CDC83CAQ46576615-B4B29BC2-6BA8-4CC3-A55A-ADE4EF03318FQ53971152-2DC1F9C1-E5E9-4F9F-91A7-5B39750782C0Q54130820-A91CB03F-9C6A-4288-9D9C-B6CF2CDAB32AQ54260674-9CB2BE27-FEA2-4EAB-946A-229224E922E4Q58207332-DEDD120A-6CB4-42EB-AD8D-5B78F49E1489
P2860
High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@en
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@nl
type
label
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@en
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@nl
prefLabel
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@en
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@nl
P2093
P356
P1476
High-dose fluconazole for trea ...... Collaborative Treatment Group.
@en
P2093
Bozzette SA
Haghighat D
Haubrich RH
McCutchan JA
P304
P356
10.1093/INFDIS/170.1.238
P407
P577
1994-07-01T00:00:00Z